Halle, Briana R.
Johnson, Douglas B.
Funding for this research was provided by:
National Cancer Institute (K23 CA204726)
Article History
Accepted: 18 January 2021
First Online: 27 February 2021
Declarations
:
: Briana R. Halle declares that she has no conflict of interest. Douglas B. Johnson receives research funding from Bristol-Myers Squibb and Incyte Corporation, and serves on advisory boards for Array BioPharma, Bristol-Myers Squibb, Catalyst Pharmaceuticals, Iovance Biotherapeutics, Janssen Pharmaceutica, Merck, Novartis, and OncoSec.